Prostaglandins, Leukotrienes and Essential Fatty Acids
Volume 82, Issue 4 , Pages 179-187 , April 2010

Polyunsaturated fatty acids in the modulation of T-cell signalling

References 

  1. Lewis RA, Austen KF, Soberman RJ. Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases. N. Eng. J. Med. 1990;323:645–655
  2. Lands WEM. Biosynthesis of prostaglandins. Ann. Rev. Nut. 1991;11:41–60
  3. Simopoulos AP. Omega-3 fatty acids in health and disease and in growth and development. Am. J. Clin. Nutr. 1991;54:438–463
  4. Serhan CN. Systems approach to inflammation resolution: identification of novel anti-inflammatory and pro-resolving mediators. J. Thromb. Haemost. 2009;7(Suppl. 1):44–48
  5. P.C. Calder, Polyunsaturated fatty acids and inflammatory processes: new twists in an old tale, Biochimie, 2009. (Epub ahead of print).
  6. Kremer JM. Clinical studies of omega-3 fatty acid suplementation in patients who have rheumatoid arthritis. Rheum. Dis. Clin. North Am. 1991;17:391–402
  7. Nielsen GL, Faarvang KL, Thomsen BS, Teglbjaerg KL, Jensen LT, Hansen TM, et al. The effects of dietary supplementation with n-3 poly-unsaturated fatty acids in patients with rheumatoid arthritis: a randomized, double blind trial. Eur. J. Clin. Invest. 1992;22:687–691
  8. Skoldstam L, Borjesson O, Kjallman A, Seiving B, Akesson B. Effect of six months of fish oil supplementation in stable rheumatoid arthritis. A double-blind, controlled study. Scand. J. Rheumatol. 1992;21:178–185
  9. Geusens P, Wouters C, Nijs J, Jiang Y, Dequeker J. Long-term effect of omega-3 fatty acid supplementation in active rheumatoid arthritis. A 12-month, double-blind, controlled study. Arthritis Rheum. 1994;37:824–829
  10. Yamashita N, Maruyama M, Yamazaki K, Hamazaki T, Yano S. Effect of eicosapentaenoic and docosahexaenoic acid on natural killer cell activity in human peripheral blood lymphocytes. Clin. Immunol. Immunopathol. 1991;59:335–345
  11. Yaqoob P, Calder PC. Effects of dietary lipid manipulation upon inflammatory mediator production by murine macrophages. Cell. Immunol. 1995;163:120–128
  12. Endres S, Meydani SN, Ghorbani R, Schindler R, Dinarello CA. Dietary supplementation with dietary fatty acids suppresses IL-2 production and monocyte cell proliferation. J. Leuk. Biol. 1993;54:599–603
  13. Meydani SN, Endres S, Woods MM, Golding BR, Soo C, Morrill-Labrode A, et al. Oral (n-3) fatty acid supplementation suppresses cytokine production and lymphocyte proliferation: comparison bcetween young and older women. J Nutr. 1991;121:547–555
  14. Jolly CA, McMurray DN, Chapkin RS. Effect of dietary n-3 fatty acids on interleukin-2 and interleukin-2 receptor expression in activated murine lymphocytes. Prostagland. Leukot. Essent. Fatty Acids. 1998;58:289–293
  15. Bittiner SB, Tucker WFG, Cartwright I, Bleehen SS. A double-blind, randomised, placebo-controlled trial of fish oil in psoriasis. Lancet. 1988;i:378–380
  16. Bjorneboe A, Soyland E, Bjorneboe G-EA, Rajka G, Drevon CA. Effect of dietary supplementation with eicosapentaenoic acid in the treatment of atopic dermatitis. Br. J. Dermatol. 1987;117:463–469
  17. Bates D, Cartlidge NEF, French JM, Jackson MJ, Nightingale S, Shaw DA, et al. A double-blind controlled trial of long chain n-3 polyinsatured fatty acids in the treatment of multiple sclerosis. J. Neurol. Neurosurg. Psychia. 1989;52:18–22
  18. Calder PC, Miles EA. Fatty acids and atopic disease. Pediatr. Allergy Immunol. 2000;13:29–36
  19. Anderson P, Delgado M. Endogenous anti-inflammatory neuropeptides and pro-resolving lipid mediators: a new therapeutic approach for immune disorders. J Cell Mol. Med. 2008;12:1830–1847
  20. Lim AK, Manley KJ, Roberts MA, Fraenkel MB. Fish oil for kidney transplant recipients. Cochrane Database Syst. Rev. 2007;18:
  21. Calder PC. Use of fish oil in parenteral nutrition: rationale and reality. Proc. Nutr. Soc. 2006;65:264–277
  22. Cantrell D. T-cell antigen receptor signal transduction pathways. Annu. Rev. Immunol. 1996;14:259–274
  23. Weiss A, Littman DR. Signal transduction by lymphocyte antigen receptor. Cell. 1994;76:263–274
  24. Clements JL, Koretzky GA. Recent developments in lymphocyte activation: linking kinases to downstream signaling events. J. Clin. Invest. 1999;103:925–929
  25. Chan AC, Iwashima M, Turck CW, Weiss A. ZAP-70 : a 70 kd protein-tyrosine kinase that associates with the TCR ξ chain. Cell. 1992;71:649–662
  26. Sieh M, Batzer A, Schlessinger J, Weiss A. GRB2 and phospholipase C-gamma1 associate with a 36- to 38-kilodalton phosphotyrosine protein after T-cell receptor stimulation. Mol. Cell. Biol. 1994;14:4435–4442
  27. Berridge MJ. Inositol tris phosphate and calcium signalling. Nature. 1993;361(1993):315–325
  28. Ward GW. CD28: a signalling perspective. Biochem. J. 1996;318:361–377
  29. Goldyne ME, Burrish GE, Paubelle P, Borgeat P. Arachidonic acid metabolism among human mononuclear leukocytes. Lipoxygenase-related pathways. J. Biol. Chem. 1984;259:8815–8819
  30. Kurland JL, Bockmann R. Prostaglandin E production by human blood monocytes and mouse peritoneal macrophages. J. Exp. Med. 1978;147:952–957
  31. Leitenberg D, Balamuth F, Bottomly K. Changes in the T cell receptor macromolecular signaling complex and membrane microdomains during T cell development and activation. Semin. Immunol. 2001;13(2001):129–138
  32. Miceli MC, Moran M, Chung CD, Patel VP, Low T, Zinnanti W. Co-stimulation and counter-stimulation: lipid raft clustering controls TCR signaling and functional outcomes. Semin. Immunol. 2001;13:115–128
  33. Simons K, Toomre D. Lipid rafts and signal transduction. Nat. Rev. Mol. Cell Biol. 2000;1:31–41
  34. Fan YY, Ly LH, Barhoumi R, McMurray DN, Chapkin RS. Dietary docosahexaenoic acid suppresses T cell protein kinase C theta lipid raft recruitment and IL-2 production. J. Immunol. 2004;173:6151–6160
  35. Geyeregger R, Zeyda M, Zlabinger GJ, Waldhausl W, Stulnig TM. Polyunsaturated fatty acids interfere with formation of the immunological synapse. J. Leukocyte Biol. 2005;77:680–688
  36. Kim W, Fan YY, Barhoumi R, Smith R, McMurray DN, Chapkin RS. n-3 polyunsaturated fatty acids suppress the localization and activation of signaling proteins at the immunological synapse in murine CD4+ T cells by affecting lipid raft formation. J. Immunol. 2008;181:6236–6243
  37. Zeyda M, Staffler G, Horejsi V, Waldhausl W, Stulnig TM. LAT displacement from lipid rafts as a molecular mechanism for the inhibition of T cell signaling by polyunsaturated fatty acids. J. Biol. Chem. 2002;277:28418–28423
  38. Stulnig TM, Huber J, Leitinger N, Imre E-M, Angelisová P, Nowotny P, et al. Polyunsaturated eicosapentaenoic acid displaces proteins from membrane rafts by altering raft lipid composition. J. Biol. Chem. 2001;276:37335–37340
  39. Zeyda M, Szekeres AB, Säemann MD, Geyeregger R, Stockinger H, Zlabinger GJ, et al. Suppression of T cell signaling by polyunsaturated fatty acids: selectivity in inhibition of mitogen-activated protein kinase and nuclear factor activation. J. Immunol. 2003;170:6033–6039
  40. Zeyda M, Stulnig TM. Lipid Rafts & Co.: an integrated model of membrane organization in T cell activation. Prog Lipid Res. 2006;45:187–202
  41. Gorjão R, Hirabara SM, de Lima TM, Cury-Boaventura MF, Curi R. Regulation of intrleukin-2 signaling by fatty acids in human lymphocytes. J Lipid Res. 2007;48:2009–2019
  42. Chapkin RS, McMurray DN, Davidson LA, Patil BS, Fan YY, Lupton JR. Bioactive dietary long-chain fatty acids: emerging mechanisms of action. Br. J. Nutr. 2008;100:1152–1157
  43. Robinson DR, Xu LL, Knoell CT, Tateno S, Olesiak W. Modification of spleen phospholipid fatty acid composition by dietary fish oil and by n-3 fatty acid ethyl esters. J. Lipid Res. 1993;34:1423–1434
  44. Shaikh SR, Dumaual AC, Castillo A, LoCascio D, Siddiqui RA, Stillwell W, et al. Oleic and docosahexaenoic acid differentially phase separate from lipid raft molecules: a comparative NMR, DSC, AFM and detergent extraction study. Biophys. J. 2004;87:1752–1766
  45. Denys A, Hichami A, Khan NA. n-3 PUFAs modulate T-cell activation via protein kinase C-alpha and -epsilon and the NF-kappaB signaling pathway. J. Lipid Res. 2005;46:752–758
  46. Gelb MH, Jain MK, Hanel AM, Berg OG. The interfacial enzymology of glycerolipid lipases: lessons from secreted phospholipases A2. Annu. Rev. Biochem. 1995;64:653–688
  47. Balboa MA, Balsinde J, Jones SS, Dennis EA. Identity between the Ca2+-independent phospholipase A2 enzymes from P388D1 macrophages and Chinese hamster ovary cells. J. Biol. Chem. 1997;272:8576–8580
  48. Le Gouvello S, Colard O, Theodorou J, Dismuth G, Tarantino N, Debre P. CD2 triggering stimulates a phospholipase A2 activity beside the phospholipase C pathway in human T lymphocytes. J. Immunol. 1990;144:2359–2364
  49. Boilard E, Surette ME. Anti-CD3 and concanavalin A-induced human T cell proliferation is associated with an increased rate of arachidonate-phospholipid remodeling. lack of involvement of group IV and group VI phospholipase A2 in remodeling and increased susceptibility of proliferating T cells to coA-independent transacylase inhibitor-induced apoptosis. J. Biol. Chem. 2001;276:18321–18326
  50. Roshak AK, Capper E, Stevenson C, Eichman C, Marshall LA. Human calcium-independent phospholipase A2 mediates lymphocyte proliferation. J. Biol. Chem. 2000;275:35692–35698
  51. Tessier C, Hichami A, Khan NA. Implication of three isoforms of PLA(2) in human T-cell proliferation. FEBS Lett. 2002;520:111–116
  52. Hichami A, Joshi B, Simonin AM, Khan NA. Role of three isoformes of phospholipase A2 in capacitative calcium influx in human T-cells. Eur. J. Biochem. 2002;269:5557–5563
  53. Lewis RS, Cahalan MD. Mitogen-induced oscillations of cytosolic Ca2+ and transmembrane Ca2+ current in human leukemic T-cells. Cell Regul. 1989;1:99–112
  54. Negulescu PA, Shastri N, Cahalan MD. Intracellular calcium dependence of gene expression in single T-lymphocytes. Proc. Natl. Acad. Sci. USA. 1994;91:2873–2877
  55. Putney JW. Type 3 inositol 1,4,5-trisphosphate receptor and capacitative calcium entry. Cell Calcium. 1997;21:257–261
  56. Oh-hora M, Rao A. Calcium signaling in lymphocytes. Curr. Opin. Immunol. 2008;20:250–258
  57. Zweifach A, Lewis RS. Mitogen regulated Ca2+ current of T-lymphocytes is activated by depletion of intracellular Ca2+ stores. Proc. Natl. Acad. Sci. USA. 1993;90(1993):6295–6299
  58. Hoth M, Penner R. Depletion of intracellular calcium stores activates a calcium current in mast cells. Nature. 1992;355(1992):353–356
  59. Chow SC, Jondal M. Polyinsatured free fatty acids stimulate an increase in cytosolic Ca2+ by mobilizing the inositol 1,4,5-trisphosphate-sensitive Ca2+ pool in T-cells through a mechanism independent of phosphoinositide turnover. J. Biol. Chem. 1990;265:902–907
  60. Aires V, Hichami A, Filomenko R, Plé A, Rébé C, Bettaieb A, et al. Docosahexaenoic acid induces increases in [Ca2+]i via inositol 1,4,5-triphosphate production and activates protein kinase C gamma and -delta via phosphatidylserine binding site: implication in apoptosis in U937 cells. Mol. Pharmacol. 2007;272:1545–1556
  61. Bonin A, Khan NA. Regulation of calcium signalling by docosahexaenoic acid in human T-cells: implication of CRAC channels. J. Lipid Res. 2000;41:277–284
  62. Denys A, Aires V, Hichami A, Khan NA. Thapsigargin-stimulated MAP kinase phosphorylation via CRAC channels and PLD activation: inhibitory action of docosahexaenoic acid. FEBS Lett. 2004;564:177–182
  63. Aires V, Hichami A, Moutairou K, Khan NA. Docosahexaenoic acid and other fatty acids induce a decrease in pHi in Jurkat T-cells. Br. J. Pharmacol. 2003;140:1217–1226
  64. Triboulot C, Hichami A, Denys A, Khan NA. Dietary (n-3) polyunsaturated fatty acids exert antihypertensive effects by modulating calcium signaling in T cells of rats. J Nutr. 2001;131:2364–2369
  65. Guermouche B, Yessoufou A, Soulimane N, Merzouk H, Moutairou K, Hichami A, et al. n-3 fatty acids modulate T-cell calcium signaling in obese macrosomic rats. Obes. Res. 2004;12:1744–1753
  66. Stulnig TM, Berger M, Sigmund T, Raederstorff D, Stockinger H, Waldhäusl W. Polyunsaturated fatty acids inhibit T cell signal transduction by modification of detergent-insoluble membrane domains. J. Cell Biol. 1998;143:637–644
  67. Nishizuka Y. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science. 1992;258:607–614
  68. Nishizuka Y. Discovery and prospect of protein kinase C research: epilogue. J. Biochem. 2003;133:155–158
  69. Khan NA, Quemener V, Moulinoux JP. Phorbol esters augment spermidine transport without protein kinase C activation. Biochem. Pharmacol. 1990;40:R1–R4
  70. Kiley SC, Jaken S. Protein kinase C: interactions and consequences. Trends Cell Biol. 1994;4:223–227
  71. Yoshida K, Asaoka Y, Nishizuka Y. Platelet activation by simultaneous actions of diacylglycerol and unsaturated fatty acid. Proc. Natl. Acad. Sci. USA. 1992;89:6443–6446
  72. McPhail LC, Clayton CC, Snyderman R. A potential second messenger role for unsaturated fatty acids: activation of Ca2+-dependent protein kinase. Science. 1984;224:622–625
  73. Shinomura T, Asaoka Y, Oka M, Yoshida K, Nishizuka Y. Role of lysophosphatidylcholine in T-lymphocyte activation: involvement of phospholipase A2 in signal transduction through protein kinase C. Proc. Natl. Acad. Sci. USA. 1991;88:5149–5153
  74. May C, Southworth AJ, Calder PC. Inhibition of lymphocyte protein kinase C by unsaturated fatty acids. Biochem. Biophys. Res. Commun. 1993;195:823–828
  75. Rossetti RG, Seiler CM, Laposata M, Zurier RB. Differential regulation of human T lymphocyte protein kinase C activity by unsaturated fatty acids. Clin. Immunol. Immunopathol. 1995;76:220–224
  76. Speizer LA, Watson MJ, Brunton LL. Differential effects of omega-3 fish oils on protein kinase activities in vitro. Am. J. Physiol. 1991;261(Endocrinol. Metab. 24):E109–E114
  77. Denys A, Hichami A, Khan NA. Eicosapentaenoic acid and docosahexaenoic acid modulate MAP kinase (ERK1/ERK2) signaling in human T cells. J Lipid Res. 2001;42:2015–2020
  78. Robbins DJ, Zhen E, Cheng M, Xu S, Ebert D, Cobb MH. MAP kinases ERKI and ERK2: pleiotropic enzymes in a ubiquitous signalling network. Adv. Cancer Res. 1994;63:93–116
  79. Whitehurst CE, Geppert D. MEK1 and the extracellular signal-regulated kinases are required for the stimulation of IL-2 gene transcription in T cells. J. Immunol. 1996;156:1020–1029
  80. Rincón M, Flavell RA, Davis RJ. Signal transduction by MAP kinases in T lymphocytes. Oncogene. 2001;20:2490–2497
  81. Hii CST, Ferrante A, Edwards YS, Huang ZH, Hartfield PJ, Rathjen DA, et al. Activation of mitogen-activated protein kinase by arachidonic acid in rat liver epithelial WB cells by a protein kinase C-dependent mechanism. J. Biol. Chem. 1995;270:4201–4204
  82. Rao GN, Baas AS, Glagow WC, Eling TE, Runge MS, Alexander RW. Activation of mitogen-activated protein kinases by arachidonic acid and its metabolites in vascular smooth muscle cells. J. Biol. Chem. 1994;269:32586–32591
  83. Dulin NO, Sorokin AS, Douglas JG. Arachidonate-induced tyrosine phosphorylation of epidermal growth factor receptor and Shc-Grb2-Sos association. Hypertension. 1998;32:1089–1093
  84. Barry OP, Kazanietz MG, Pratico D, FitzGerald GA. Arachidonic acid in platelet microparticles up-regulates cyclooxygenase-2-dependent prostaglandin formation via a protein kinase C/mitogen-activated protein kinase-dependent pathway. J. Biol. Chem. 1999;274:7545–7556
  85. Denys A, Hichami A, Khan NA. Eicosapentaenoic acid and docosahexaenoic acid modulate MAP kinase enzyme activity in human T-cells. Mol. Cell Biochem. 2002;232:143–148
  86. Denys A, Hichami A, Maume B, Khan NA. Docosahexaenoic acid modulates phorbol ester-induced activation of extracellular signal-regulated kinases 1 and 2 in NIH/3T3 cells. Lipids. 2001;36:813–818
  87. Massaro A, Habib L, Lubrano SD, Turco G, Lazzerini T, Bourcier BB, et al. De Caterina, The omega-3 fatty acid docosahexaenoate attenuates endothelial cyclooxygenase-2 induction through both NADP(H) oxidase and PKC{varepsilon} inhibition. Proc. Natl. Acad. Sci. USA. 2006;103:15184–15189
  88. Hagiwara S, Makita Y, Gu L, Tanimoto M, Zhang M, Nakamura S, et al. Eicosapentaenoic acid ameliorates diabetic nephropathy of type 2 diabetic KKAy/Ta mice: involvement of MCP-1 suppression and decreased ERK1/2 and p38 phosphorylation. Nephrol. Dial. Transplant. 2006;21:605–615
  89. Kim HH, Shin CM, Park C-H, Kim KH, Cho KH, Eun HC, et al. Eicosapentaenoic acid inhibits UV-induced MMP-1 expression in human dermal fibroblasts. J. Lipid Res. 2005;46:1712–1720
  90. Lo CJ, Chiu KC, Fu M, Chu A, Helton S. Fish oil modulates macrophage P44/P42 mitogen-activated protein kinase activity induced by lipopolysaccharide. J. Parenter. Enter. Nutr. 2000;24:159–163
  91. Bousserouel S, Brouillet A, Bereziat G, Raymondjean M, Andreani M. Different effects of n-6 and n-3 polyunsaturated fatty acids on the activation of rat smoothmuscle cells by interleukin-1β. J. Lipid Res. 2003;44:601–611
  92. Yessoufou A, Plé A, Moutairou K, Hichami A, Khan NA. DHA reduces suppressive and migratory functions of Treg cells. J. Lipid Res. 2009;27;[Epub ahead of print]
  93. Bechoua S, Dubois M, Némoz G, Lagarde M, Prigent AF. Docosahexaenoic acid lowers phosphatidate level in human activated lymphocytes despite phospholipase D activation. J Lipid Res. 1998;39:873–883
  94. Madani S, Hichami A, Cherkaoui-Malki M, Khan NA. Diacylglycerols containing Omega 3 and Omega 6 fatty acids bind to RasGRP and modulate MAP kinase activation. J. Biol. Chem. 2004;279:1176–1183
  95. Fowler KH, McMurray DN, Fan YY, Aukema HM, Chapki RS. Purified dietary n-3 polyunsaturated fatty acids alter diacylglycerol mass and molecular species composition in concanavalin A-stimulated murine splenocytes. Biochim. Biophys. Acta. 1993;1210:89–96
  96. Montell C. Drosophila TRP channels. Pflugers Arch. 2005;451:19–28
  97. Hofmann T, Obukhov AG, Schaefer M, Harteneck C, Gudermann T, Schultz G. Direct activation of human TRPC6 and TRPC3 channels by diacylglycerol. Nature. 1999;397:259–263
  98. Gamberucci A, Giurisato E, Pizzo P, Tassi M, Giunti R, McIntosh DP, et al. Diacylglycerol activates the influx of extracellular cations in T-lymphocytes independently of intracellular calcium-store depletion and possibly involving endogenous TRP6 gene products. Biochem. J. 2002;364:245–254
  99. Aires V, Hichami A, Boulay G, Khan NA. Activation of TRPC6 calcium channels by diacylglycerol (DAG)-containing arachidonic acid: a comparative study with DAG-containing docosahexaenoic acid. Biochimie. 2007;89:926–937
  100. Izquierdo M, Downward J, Graves JD, Cantrell DA. Role of protein kinase C in T-cell antigen receptor regulation of p21ras: evidence that two p21ras regulatory pathways coexist in T cells. Mol. Cell. Biol. 1992;12:3305–3312
  101. Downward J. Regulation of p21ras by GTPase activating proteins and guanine nucleotide exchange proteins. Curr. Opin. Genet. Dev. 1992;2:13–18
  102. Zhang XF, Kyriakis JM, Takeuchi-Suzuki E, Elledge E, Marchall MS, Bruder JT, et al. Normal and oncogenic p21 ras proteins bind to the amino acid terminal regulatory domain of c-Raf-1. Nature. 1993;364:308–313
  103. Kyriakis JM, App H, Zhang XF, Banerjee P, Brautigan DL, Rapp UR, et al. activates MAP kinase-kinase. Nature. 1992;358:417–421
  104. Ebinu O, Bottorff DA, Chan EY, Stang SL, Dunn RJ, Stone JC. RasGRP, a Ras guanyl nucleotide- releasing protein with calcium- and diacylglycerol-binding motifs. Science. 1998;280(1998):1082–1086
  105. Lorenzo PS, Beheshti M, Pettit GR, Stone JC, Blumberg PM. The guanine nucleotide exchange factor RasGRP is a high -affinity target for diacylglycerol and phorbol esters. Mol. Pharmacol. 2000;57:840–846
  106. Marignani PA, Epand RM, Sebaldt RJ. Acyl chain dependence of diacylglycerol activation of protein kinase C activity in vitro. Biochem. Biophys. Res. Commun. 1996;225:469–473
  107. Ziboh VA, Miller CC, Cho Y. Metabolism of polyunsaturated fatty acids by skin epidermal enzymes: generation of antiinflammatory and antiproliferative metabolites. Am. J. Clin. Nutr. 2000;71:361S–366S
  108. Bordoni A, Biagi PL, Turchetto E, Rossi CA, Hrelia S. The correlation between the acidic composition of diacylglycerol and protein kinase C activation in cultures of rat cardiomyocytes. Cardiologia. 1992;37:631–634
  109. Jolly CA, Jiang YH, Chapkin RS, McMurray DN. Dietary n-3 polyunsaturated fatty acid modulation of murine lymphoproliferation and interleukin-2 secretion: correlation with alteration in diacylglycerol and ceramide mass. J. Nutr. 1997;127:37–43
  110. McMurray DN, Jolly CA, Chapkin RS. Effect of dietary n-3 fatty acids on T cell activation and T cell receptor mediated signalling in a murine model. J. Infect Dis. 2000;182:S103–S107
  111. Madani S, Hichami A, Legrand A, Belleville J, Khan NA. Implication of acyl chain of diacylglycerols in activation of different isoforms of protein kinase C. FASEB J. 2001;15(2001):2595–2601
  112. Judé S, Martel E, Vincent F, Besson P, Couet C, Ogilvie GK, et al. Dietary long-chain n-3 fatty acids modify blood and cardiac phospholipids and reduce protein kinase-C-delta and protein kinase-C-epsilon translocation. Br. J. Nutr. 2007;98:1143–1151
  113. Cooper JA. Straight and narrow or tortuous and intersecting?. Curr. Biol. 1994;4:1118–1121
  114. Ly LH, Smith R, Switzer KC, Chapkin RS, McMurray DN. Dietary eicosapentaenoic acid modulates CTLA-4 expression in murine CD4+ T-cells. Prostagland. Leukot. Essent. Fatty Acids. 2006;74:29–37
  115. Ly LH, Smith R, Chapkin RS, McMurray DN. Dietary n-3 polyunsaturated fatty acids suppress splenic CD4(+) T cell function in interleukin (IL)-10(-/-) mice. Clin. Exp. Immunol. 2005;139:202–209
  116. Imboden J, Weyand C, Goronzy J. Antigen recognition by a human T cell clone leads to increases in inositol trisphosphate. J Immunol. 1987;138:1322–1324
  117. Billah MM, Anthes JC. The regulation and cellular functions of phosphatidylcholine hydrolysis. Biochem. J. 1990;269:281–291
  118. Khan NA, Hichami A. Ionotrophic 5-hydroxytryptamine type 3 receptor activates the protein kinase C-dependent phospholipase D pathway in human T-cells. Biochem. J. 1999;344:199–204
  119. El Bawab S, Macovschi O, Thevenon C, Goncalves A, Némoz G, Lagarde M, et al. Contribution of phosphoinositides and phosphatidylcholines to the production of phosphatidic acid upon concanavalin A stimulation of rat thymocytes. J. Lipid Res. 1996;37:2098–2108
  120. Jain J, Loh C, Rao A. Transcriptional regulation of the IL-2 gene. Curr. Opin. Immunol. 1995;7:333–342
  121. Diep QN, Touyz RM, Schiffrin EL. Docosahexaenoic acid, a peroxisome proliferator-activated receptor-{alpha} ligand, induces apoptosis in vascular smooth muscle cells by stimulation of p38 mitogen-activated protein kinase. Hypertension. 2000;36:851–855
  122. Avula CP, Zaman AK, Lawrence R, Fernandes G. Induction of apoptosis and apoptotic mediators in balb/c splenic lymphocytes by dietary n-3 and n-6 fatty acids. Lipids. 1999;34:921–927
  123. Zong ZP, Matsui S, Han JF, Katsuda S, Fu ML. Involvement of thymus in amiodarone-treated autoimmune myocarditis in rat. Int. J. Cardiol. 2008;125:122–129

PII: S0952-3278(10)00067-0

doi: 10.1016/j.plefa.2010.02.023

Prostaglandins, Leukotrienes and Essential Fatty Acids
Volume 82, Issue 4 , Pages 179-187 , April 2010

Article Tools

* Image Usage & Resolution